The innovative drug Polyhemostat in the treatment of bleeding

DOI: https://doi.org/10.29296/25877305-2018-07-07
Download full text PDF
Issue: 
7
Year: 
2018

Professor V. Zubritsky(1), MD; Professor V. Kukes(2), MD, Academician of the Russian Academy of Sciences; Professor R. Chilova(3), MD; V. Vechorko(4); I. Tarasov(5), Candidate of Medical Sciences; G. Proklova(3) 1-Institute of Sociomedical Technologies, Moscow State University of Food Production 2-Research Center for Examination of Medical Products, Ministry of Health of the Russian Federation, Moscow 3-I.M. Sechenov First Moscow State Medical University (Sechenov University) 4-O.M. Filatov City Clinical Hospital Fifteen, Moscow 5-Lyubertsy District Hospital Two

The innovative drug Polyhemostat has been designed and patented by Russian scientists and registered by the Ministry of Health of the Russian Federation. The drug has been undergone pre- and post-registration clinical studies in a number of leading Russian clinics and military hospitals. The paper considers the experience in topically applying Polyhemostat.

Keywords: 
Polyhemostat
hemostasis
bleeding
adhesion



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.